The mechanisms by which SGLT-2 inhibitors could preserve RKF include reduction in intraglomerular pressure through renal hemodynamic effects and albuminuria, decrease in oxidative stress and inflammation, and attenuation of renal fibrosis [12,22,23,24,25,26]. Here, SLC5A2 is linked to renal fibrosis.